Cálculo
ROA | = | 100 | × | Ingresos netos atribuibles a Pfizer Inc.1 | ÷ | Activos totales1 | |
---|---|---|---|---|---|---|---|
31 dic. 2021 | 12.11% | = | 100 | × | 21,979 | ÷ | 181,476 |
31 dic. 2020 | 6.23% | = | 100 | × | 9,616 | ÷ | 154,229 |
31 dic. 2019 | 9.72% | = | 100 | × | 16,273 | ÷ | 167,489 |
31 dic. 2018 | 7.00% | = | 100 | × | 11,153 | ÷ | 159,422 |
31 dic. 2017 | 12.40% | = | 100 | × | 21,308 | ÷ | 171,797 |
31 dic. 2016 | 4.20% | = | 100 | × | 7,215 | ÷ | 171,615 |
31 dic. 2015 | 4.16% | = | 100 | × | 6,960 | ÷ | 167,460 |
31 dic. 2014 | 5.40% | = | 100 | × | 9,135 | ÷ | 169,274 |
31 dic. 2013 | 12.78% | = | 100 | × | 22,003 | ÷ | 172,101 |
31 dic. 2012 | 7.84% | = | 100 | × | 14,570 | ÷ | 185,798 |
31 dic. 2011 | 5.32% | = | 100 | × | 10,009 | ÷ | 188,002 |
31 dic. 2010 | 4.23% | = | 100 | × | 8,257 | ÷ | 195,014 |
31 dic. 2009 | 4.05% | = | 100 | × | 8,635 | ÷ | 212,949 |
31 dic. 2008 | 7.29% | = | 100 | × | 8,104 | ÷ | 111,148 |
31 dic. 2007 | 7.07% | = | 100 | × | 8,144 | ÷ | 115,268 |
31 dic. 2006 | 16.84% | = | 100 | × | 19,337 | ÷ | 114,837 |
31 dic. 2005 | 6.88% | = | 100 | × | 8,085 | ÷ | 117,565 |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
1 US$ en millones
Comparación con los competidores
Pfizer Inc. | AbbVie Inc. | Amgen Inc. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Zoetis Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|
31 dic. 2021 | 12.11% | 7.88% | 9.63% | 11.44% | 9.16% | 11.47% | 12.35% | 49.46% | 31.75% | 8.12% | 14.65% |
31 dic. 2020 | 6.23% | 3.07% | 11.54% | 13.28% | 0.18% | 8.41% | 7.72% | -10.18% | 20.47% | 9.23% | 12.04% |
31 dic. 2019 | 9.72% | 8.84% | 13.13% | 21.17% | 8.74% | 9.59% | 11.66% | -32.34% | 14.29% | 6.33% | 12.99% |
31 dic. 2018 | 7.00% | 9.58% | 12.64% | 7.36% | 8.57% | 10.00% | 7.53% | -19.61% | 20.83% | 5.22% | 13.25% |
31 dic. 2017 | 12.40% | 7.50% | 2.48% | -0.45% | 6.58% | 0.83% | 2.72% | — | 13.67% | 3.93% | 10.06% |
31 dic. 2016 | 4.20% | 9.01% | 9.95% | 7.05% | 23.70% | 11.71% | 4.11% | — | 12.84% | 4.40% | 10.73% |
31 dic. 2015 | 4.16% | 9.70% | 9.69% | 6.77% | 34.93% | 11.55% | 4.36% | — | 11.34% | 4.83% | 4.28% |
31 dic. 2014 | 5.40% | 6.44% | 7.47% | 6.43% | 34.91% | 12.45% | 12.12% | — | 8.99% | 4.42% | 8.82% |
31 dic. 2013 | 12.78% | 14.14% | 7.68% | 13.29% | 13.67% | 10.42% | 4.17% | — | 14.38% | 4.00% | 7.69% |
31 dic. 2012 | 7.84% | 19.53% | 8.00% | 11.89% | 12.20% | 8.94% | 5.81% | — | 36.06% | 4.29% | 6.96% |
31 dic. 2011 | 5.32% | — | 7.54% | 12.92% | 16.20% | 8.51% | 5.97% | — | -16.75% | 4.96% | — |
31 dic. 2010 | 4.23% | — | 10.64% | 16.35% | 25.03% | 12.96% | 0.81% | — | -9.59% | 4.85% | — |
31 dic. 2009 | 4.05% | — | 11.62% | 15.76% | 27.18% | 12.95% | 11.51% | — | -9.15% | 3.93% | — |
31 dic. 2008 | 7.29% | — | 11.51% | -7.09% | 28.65% | 15.25% | 16.54% | — | -12.34% | 4.71% | — |
31 dic. 2007 | 7.07% | — | 9.14% | 11.02% | 27.68% | 13.06% | 6.77% | — | -11.28% | 3.59% | — |
31 dic. 2006 | 16.84% | — | 8.73% | 12.13% | -29.12% | 15.67% | 9.95% | — | -17.49% | 0.79% | — |
31 dic. 2005 | 6.88% | — | 12.54% | 8.05% | 21.62% | 17.94% | 10.33% | — | -22.54% | 5.25% | — |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
Comparación con el sector industrial: Productos farmacéuticos, biotecnología y ciencias de la vida
Pfizer Inc., ROA, tendencias a largo plazo, comparación con el sector industrial: productos farmacéuticos, biotecnología y ciencias de la vida
Pfizer Inc. | Productos farmacéuticos, biotecnología y ciencias de la vida | |
---|---|---|
31 dic. 2021 | 12.11% | 12.09% |
31 dic. 2020 | 6.23% | 7.05% |
31 dic. 2019 | 9.72% | 10.39% |
31 dic. 2018 | 7.00% | 8.72% |
31 dic. 2017 | 12.40% | 5.42% |
31 dic. 2016 | 4.20% | 8.66% |
31 dic. 2015 | 4.16% | 9.32% |
31 dic. 2014 | 5.40% | 9.93% |
31 dic. 2013 | 12.78% | 9.82% |
31 dic. 2012 | 7.84% | 8.58% |
31 dic. 2011 | 5.32% | 7.09% |
31 dic. 2010 | 4.23% | 7.02% |
31 dic. 2009 | 4.05% | 8.90% |
31 dic. 2008 | 7.29% | 10.04% |
31 dic. 2007 | 7.07% | 9.10% |
31 dic. 2006 | 16.84% | 12.61% |
31 dic. 2005 | 6.88% | 10.51% |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
Comparación con la industria: Cuidado de la salud
Pfizer Inc. | Cuidado de la salud | |
---|---|---|
31 dic. 2021 | 12.11% | 9.21% |
31 dic. 2020 | 6.23% | 5.32% |
31 dic. 2019 | 9.72% | 7.53% |
31 dic. 2018 | 7.00% | 6.61% |
31 dic. 2017 | 12.40% | 5.34% |
31 dic. 2016 | 4.20% | 7.23% |
31 dic. 2015 | 4.16% | 7.58% |
31 dic. 2014 | 5.40% | 8.51% |
31 dic. 2013 | 12.78% | 8.64% |
31 dic. 2012 | 7.84% | 7.97% |
31 dic. 2011 | 5.32% | 7.23% |
31 dic. 2010 | 4.23% | 7.21% |
31 dic. 2009 | 4.05% | 9.55% |
31 dic. 2008 | 7.29% | 9.17% |
31 dic. 2007 | 7.07% | 8.58% |
31 dic. 2006 | 16.84% | 10.43% |
31 dic. 2005 | 6.88% | 9.67% |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).